AAAAAA

   
Results: 1-25 | 26-42
Results: 1-25/42
HIGH-DOSE THERAPY WITH AUTOLOGOUS HEMATOPOIETIC SUPPORT IN PATIENTS WITH TRANSFORMED FOLLICULAR LYMPHOMA - A STUDY OF 27 PATIENTS FROM A SINGLE-CENTER
Authors: FORAN JM APOSTOLIDIS J PAPAMICHAEL D NORTON AJ MATTHEWS J AMESS JAL LISTER RA ROHATINER AZS
Citation: Jm. Foran et al., HIGH-DOSE THERAPY WITH AUTOLOGOUS HEMATOPOIETIC SUPPORT IN PATIENTS WITH TRANSFORMED FOLLICULAR LYMPHOMA - A STUDY OF 27 PATIENTS FROM A SINGLE-CENTER, Annals of oncology, 9(8), 1998, pp. 865-869
USE OF THE POLYMERASE-CHAIN-REACTION AND DIRECT SEQUENCING ANALYSIS TO DETECT CELLS WITH THE T(14-18) IN AUTOLOGOUS BONE-MARROW FROM PATIENTS WITH FOLLICULAR LYMPHOMA, BEFORE AND AFTER IN-VITRO TREATMENT
Authors: PAPPA VI WILKES S SALAM A YOUNG BD LISTER TA ROHATINER AZS
Citation: Vi. Pappa et al., USE OF THE POLYMERASE-CHAIN-REACTION AND DIRECT SEQUENCING ANALYSIS TO DETECT CELLS WITH THE T(14-18) IN AUTOLOGOUS BONE-MARROW FROM PATIENTS WITH FOLLICULAR LYMPHOMA, BEFORE AND AFTER IN-VITRO TREATMENT, Bone marrow transplantation, 22(6), 1998, pp. 553-558
PERIPHERAL-BLOOD PROGENITOR CELLS (PBPC) MOBILIZED WITH G-CSF ALONE WITH OR WITHOUT CD34 POSITIVE SELECTION TO SUPPORT MYELOABLATIVE THERAPY (MT) IN PRETREATED PATIENTS (PTS) WITH HEMATOLOGICAL MALIGNANCIES
Authors: APOSTOLIDIS J GUPTA RK FORAN J PENSON R OKUKENU E SALAM A LEONHARDT M LISTER TA ROHATINER AZS
Citation: J. Apostolidis et al., PERIPHERAL-BLOOD PROGENITOR CELLS (PBPC) MOBILIZED WITH G-CSF ALONE WITH OR WITHOUT CD34 POSITIVE SELECTION TO SUPPORT MYELOABLATIVE THERAPY (MT) IN PRETREATED PATIENTS (PTS) WITH HEMATOLOGICAL MALIGNANCIES, British Journal of Haematology, 102(1), 1998, pp. 77-77
MYELOABLATIVE THERAPY WITH AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT) AS CONSOLIDATION OF FIRST-REMISSION IN YOUNGER PATIENTS WITH ACUTEMYELOGENOUS LEUKEMIA (AML)
Authors: SLATER SE ROHATINER AZS BASSAN R RAIMONDI R AMESS J CARTER M ARNOTT S PERSONEN A RODEGHIERO F BARBUI T LISTER TA
Citation: Se. Slater et al., MYELOABLATIVE THERAPY WITH AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT) AS CONSOLIDATION OF FIRST-REMISSION IN YOUNGER PATIENTS WITH ACUTEMYELOGENOUS LEUKEMIA (AML), British Journal of Haematology, 102(1), 1998, pp. 107-107
LOW-DOSE CONTINUOUS CHEMOTHERAPY IN REFRACTORY LYMPHOMA
Authors: SHAMASH J APOSTOLIDIS J FORAN JM GUPTA RK KELSEY SM ROHATINER AZS LISTER TA
Citation: J. Shamash et al., LOW-DOSE CONTINUOUS CHEMOTHERAPY IN REFRACTORY LYMPHOMA, British Journal of Haematology, 102(1), 1998, pp. 118-118
IMMUNOTHERAPY OF MANTLE CELL LYMPHOMA (MCL), LYMPHOPLASMACYTOID LYMPHOMA (LPC) AND WALDENSTROMS MACROGLOBULINEMIA (WM), AND SMALL LYMPHOCYTIC LYMPHOMA (SLL) WITH RITUXIMAB (IDEC-C288) - PRELIMINARY-RESULTS OF AN ONGOING INTERNATIONAL MULTICENTER TRIAL
Authors: FORAN JM ROHATINER AZS CUNNINGHAM D POPESCU R SOLAICELIGNY P CAVALLI F COIFFIER B JOHNSON P GISSELBRECHT C HAIOUN C BESSELL E SWEETENHAM J RADFORD J BENZOHRA A LISTER TA
Citation: Jm. Foran et al., IMMUNOTHERAPY OF MANTLE CELL LYMPHOMA (MCL), LYMPHOPLASMACYTOID LYMPHOMA (LPC) AND WALDENSTROMS MACROGLOBULINEMIA (WM), AND SMALL LYMPHOCYTIC LYMPHOMA (SLL) WITH RITUXIMAB (IDEC-C288) - PRELIMINARY-RESULTS OF AN ONGOING INTERNATIONAL MULTICENTER TRIAL, British Journal of Haematology, 102(1), 1998, pp. 149-149
IMMUNOTHERAPY OF RECURRENT FOLLICULAR LYMPHOMA (FL) WITH RITUXIMAB (IDEC-C2B8) - PRELIMINARY-RESULTS OF AN ONGOING UK MULTICENTER TRIAL
Authors: FORAN JM ROHATINER AZS CUNNINGHAM D POPESCU R GOLDSTONE AH SWEETENHAM J JOHNSON P BESSELL E PETTENGELL R HANCOCK B LISTER TA
Citation: Jm. Foran et al., IMMUNOTHERAPY OF RECURRENT FOLLICULAR LYMPHOMA (FL) WITH RITUXIMAB (IDEC-C2B8) - PRELIMINARY-RESULTS OF AN ONGOING UK MULTICENTER TRIAL, British Journal of Haematology, 102(1), 1998, pp. 243-243
DETECTION OF SOMATIC MUTATIONS OF THE BCL-2 ONCOGENE IN B-CELL LYMPHOMAS WITH THE T(14-18)
Authors: PAPPA VI WILKES S NORTON A PHILLIPS S ROHATINER AZS LISTER TA YOUNG BD
Citation: Vi. Pappa et al., DETECTION OF SOMATIC MUTATIONS OF THE BCL-2 ONCOGENE IN B-CELL LYMPHOMAS WITH THE T(14-18), International journal of oncology, 11(3), 1997, pp. 481-488
TREATMENT OF ACUTE MYELOGENOUS LEUKEMIA
Authors: SLATER S ROHATINER AZS MURPHY M AMESS J CARTER M LISTER TA JOHNSON S EWINGS M
Citation: S. Slater et al., TREATMENT OF ACUTE MYELOGENOUS LEUKEMIA, Journal of clinical oncology, 15(4), 1997, pp. 1710-1710
CONCENTRATED CD34(+) CELLS DERIVED FROM THE BLOOD TO SUPPORT MYELOABLATIVE THERAPY IN PATIENTS WITH FOLLICULAR LYMPHOMA
Authors: APOSTOLIDIS J GUPTA RK SUMMERS K LEDCHUMYKANTHAN K OKUKENU E SALAM A LISTER TA ROHATINER AZS
Citation: J. Apostolidis et al., CONCENTRATED CD34(+) CELLS DERIVED FROM THE BLOOD TO SUPPORT MYELOABLATIVE THERAPY IN PATIENTS WITH FOLLICULAR LYMPHOMA, Blood, 90(10), 1997, pp. 4321-4321
MOLECULAR FOLLOW-UP OF PATIENTS CONSOLIDATED WITH MYELOABLATIVE THERAPY AND AUTOLOGOUS BONE-MARROW SUPPORT FOR FOLLICULAR LYMPHOMA
Authors: APOSTOLIDIS J GUPTA RK JOHNSON PWM MORRESEY K LEDCHUMYKANTHAN K MATTHEWS J LISTER TA ROHATINER AZS
Citation: J. Apostolidis et al., MOLECULAR FOLLOW-UP OF PATIENTS CONSOLIDATED WITH MYELOABLATIVE THERAPY AND AUTOLOGOUS BONE-MARROW SUPPORT FOR FOLLICULAR LYMPHOMA, Blood, 90(10), 1997, pp. 502-502
ROLE OF IMAGE-GUIDED CORE-NEEDLE BIOPSY IN THE MANAGEMENT OF PATIENTSWITH LYMPHOMA
Authors: PAPPA VI HUSSAIN HK REZNEK RH WHELAN J NORTON AJ WILSON AM LOVE J LISTER TA ROHATINER AZS
Citation: Vi. Pappa et al., ROLE OF IMAGE-GUIDED CORE-NEEDLE BIOPSY IN THE MANAGEMENT OF PATIENTSWITH LYMPHOMA, Journal of clinical oncology, 14(9), 1996, pp. 2427-2430
MITOXANTRONE AND CYTOSINE-ARABINOSIDE AS TREATMENT FOR ACUTE MYELOBLASTIC-LEUKEMIA IN OLDER PATIENTS
Authors: MACCALLUM PK ROHATINER AZS DAVIS CL WHELAN JS OZA AM LIM J LOVE S AMESS JAL LEAHY M GUPTA RK PRICE CGA LISTER TA
Citation: Pk. Maccallum et al., MITOXANTRONE AND CYTOSINE-ARABINOSIDE AS TREATMENT FOR ACUTE MYELOBLASTIC-LEUKEMIA IN OLDER PATIENTS, Annals of hematology, 71(1), 1995, pp. 35-39
NODULAR TYPE OF LYMPHOCYTE PREDOMINANT HODGKINS-DISEASE - A CLINICAL-STUDY OF 58 CASES
Authors: PAPPA VI NORTON AJ GUPTA RK WILSON AM ROHATINER AZS LISTER TA
Citation: Vi. Pappa et al., NODULAR TYPE OF LYMPHOCYTE PREDOMINANT HODGKINS-DISEASE - A CLINICAL-STUDY OF 58 CASES, Annals of oncology, 6(6), 1995, pp. 559-565
MANTLE CELL LYMPHOMA - NATURAL-HISTORY DEFINED IN A SERIALLY BIOPSIEDPOPULATION OVER A 20-YEAR PERIOD
Authors: NORTON AJ MATTHEWS J PAPPA V SHAMASH J LOVE S ROHATINER AZS LISTER TA
Citation: Aj. Norton et al., MANTLE CELL LYMPHOMA - NATURAL-HISTORY DEFINED IN A SERIALLY BIOPSIEDPOPULATION OVER A 20-YEAR PERIOD, Annals of oncology, 6(3), 1995, pp. 249-256
MYELOMA DURING A DECADE - CLINICAL-EXPERIENCE IN A SINGLE-CENTER
Authors: MALPAS JS GANJOO RK JOHNSON PWM MAHMOUD MM WILLIAMS AH CARTER M GREGORY W LIM JM LOVE SB CLARK PI OSBORNE RJ RICHARDS MA AMESS JAL ROHATINER AZS SLEVIN ML WRIGLEY PFM LISTER TA
Citation: Js. Malpas et al., MYELOMA DURING A DECADE - CLINICAL-EXPERIENCE IN A SINGLE-CENTER, Annals of oncology, 6(1), 1995, pp. 11-18
MYELO-ABLATIVE THERAPY WITH PERIPHERAL-BLOOD PROGENITOR-CELL (PBPC) SUPPORT IN PATIENTS WITH HEMATOLOGICAL MALIGNANCY
Authors: PIGADITOU A MARINI G JOHNSON PWM MAHMOUD M OKUKENU E ADAMS K SALAM A AMESS JAL NORTON AJ MURPHY MF CARTER M DALE CR MALPAS JS LISTER TA ROHATINER AZS
Citation: A. Pigaditou et al., MYELO-ABLATIVE THERAPY WITH PERIPHERAL-BLOOD PROGENITOR-CELL (PBPC) SUPPORT IN PATIENTS WITH HEMATOLOGICAL MALIGNANCY, Annals of oncology, 6(1), 1995, pp. 53-58
INDUCTION OF CD80 EXPRESSION IN LOW-GRADE B-CELL LYMPHOMA - A POTENTIAL IMMUNOTHERAPEUTIC TARGET
Authors: SHAMASH J DAVIES DC SALAM A ROHATINER AZS YOUNG BD LISTER TA
Citation: J. Shamash et al., INDUCTION OF CD80 EXPRESSION IN LOW-GRADE B-CELL LYMPHOMA - A POTENTIAL IMMUNOTHERAPEUTIC TARGET, Leukemia, 9(8), 1995, pp. 1349-1352
RESULTS OF A RANDOMIZED TRIAL COMPARING MVPP CHEMOTHERAPY WITH A HYBRID REGIMEN, CHLVPP EVA, IN THE INITIAL TREATMENT OF HODGKINS-DISEASE/
Authors: RADFORD JA CROWTHER D ROHATINER AZS RYDER WDJ GUPTA RK OZA A DEAKIN DP ARNOTT S WILKINSON PM JAMES RD JOHNSON RJ LISTER TA
Citation: Ja. Radford et al., RESULTS OF A RANDOMIZED TRIAL COMPARING MVPP CHEMOTHERAPY WITH A HYBRID REGIMEN, CHLVPP EVA, IN THE INITIAL TREATMENT OF HODGKINS-DISEASE/, Journal of clinical oncology, 13(9), 1995, pp. 2379-2385
PATTERNS OF SURVIVAL IN PATIENTS WITH RECURRENT FOLLICULAR LYMPHOMA -A 20-YEAR STUDY FROM A SINGLE-CENTER
Authors: JOHNSON PWM ROHATINER AZS WHELAN JS PRICE CGA LOVE S LIM J MATTHEWS J NORTON AJ AMESS JAL LISTER TA
Citation: Pwm. Johnson et al., PATTERNS OF SURVIVAL IN PATIENTS WITH RECURRENT FOLLICULAR LYMPHOMA -A 20-YEAR STUDY FROM A SINGLE-CENTER, Journal of clinical oncology, 13(1), 1995, pp. 140-147
PROLONGED REQUIREMENT FOR PLATELET TRANSFUSIONS AFTER MYELOABLATIVE THERAPY
Authors: MURPHY MF OKUKENU E ROHATINER AZS LISTER TA
Citation: Mf. Murphy et al., PROLONGED REQUIREMENT FOR PLATELET TRANSFUSIONS AFTER MYELOABLATIVE THERAPY, Blood, 86(10), 1995, pp. 398-398
WEEKLY VAPEC-B CHEMOTHERAPY FOR HIGH-GRADE NON-HODGKINS-LYMPHOMA - RESULTS OF TREATMENT IN 184 PATIENTS
Authors: RADFORD JA WHELAN JS ROHATINER AZS DEAKIN D HARRIS M STANSFELD AG SWINDELL R WILKINSON PM JAMES RD LISTER TA CROWTHER D
Citation: Ja. Radford et al., WEEKLY VAPEC-B CHEMOTHERAPY FOR HIGH-GRADE NON-HODGKINS-LYMPHOMA - RESULTS OF TREATMENT IN 184 PATIENTS, Annals of oncology, 5(2), 1994, pp. 147-151
MYELOABLATIVE THERAPY WITH AUTOLOGOUS BONE-MARROW TRANSPLANTATION AS CONSOLIDATION THERAPY FOR FOLLICULAR LYMPHOMA
Authors: ROHATINER AZS FREEDMAN A NADLER L LIM J LISTER TA
Citation: Azs. Rohatiner et al., MYELOABLATIVE THERAPY WITH AUTOLOGOUS BONE-MARROW TRANSPLANTATION AS CONSOLIDATION THERAPY FOR FOLLICULAR LYMPHOMA, Annals of oncology, 5, 1994, pp. 190000143-190000146
MYELOABLATIVE THERAPY WITH AUTOLOGOUS BONE-MARROW TRANSPLANTATION AS CONSOLIDATION THERAPY FOR RECURRENT FOLLICULAR LYMPHOMA
Authors: ROHATINER AZS JOHNSON PWM PRICE CGA ARNOTT SJ AMESS JAL NORTON AJ DOREY E ADAMS K WHELAN JS MATTHEWS J MACCALLUM PK OZA AM LISTER TA
Citation: Azs. Rohatiner et al., MYELOABLATIVE THERAPY WITH AUTOLOGOUS BONE-MARROW TRANSPLANTATION AS CONSOLIDATION THERAPY FOR RECURRENT FOLLICULAR LYMPHOMA, Journal of clinical oncology, 12(6), 1994, pp. 1177-1184
DETECTION OF CELLS BEARING THE T(1418) TRANSLOCATION FOLLOWING MYELOABLATIVE TREATMENT AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR FOLLICULAR LYMPHOMA
Authors: JOHNSON PWM PRICE CGA SMITH T COTTER FE MEERABUX J ROHATINER AZS YOUNG BD LISTER TA
Citation: Pwm. Johnson et al., DETECTION OF CELLS BEARING THE T(1418) TRANSLOCATION FOLLOWING MYELOABLATIVE TREATMENT AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR FOLLICULAR LYMPHOMA, Journal of clinical oncology, 12(4), 1994, pp. 798-805
Risultati: 1-25 | 26-42